Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes
2011

Palmitoleic Acid Helps Diabetic Mice

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Yang Zhi-Hong, Miyahara Hiroko, Hatanaka Akimasa

Primary Institution: Central Research Laboratory, Tokyo Innovation Center, Nippon Suisan Kaisha, Ltd.

Hypothesis

Does palmitoleic acid have an antidiabetic effect in KK-Ay mice?

Conclusion

Palmitoleic acid improves insulin sensitivity and reduces hyperglycemia and hypertriglyceridemia in diabetic mice.

Supporting Evidence

  • Palmitoleic acid reduced body weight increase in diabetic mice.
  • It improved insulin sensitivity and reduced plasma glucose levels.
  • Hepatic triglyceride levels were lower in the palmitoleic acid group.
  • Proinflammatory gene expressions were down-regulated in adipose tissue.

Takeaway

Giving palmitoleic acid to mice with diabetes helped them use insulin better and reduced their blood sugar and fat levels.

Methodology

KK-Ay mice were given either palmitoleic acid, palmitic acid, or a control for 4 weeks, and various metabolic parameters were measured.

Limitations

The study was conducted on a specific mouse model, which may not fully represent human diabetes.

Participant Demographics

Six-week-old male KK-Ay mice.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-511X-10-120

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication